CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 125 enrolled
Drug / intervention
Continuous positive airway pressure treatmentprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01508754
NCT01508754Phase 4Completed
CompareCT.gov

Efficacy of Continuous Positive Airway Pressure (CPAP) on Blood Pressure Control of Resistant Hypertension Patients With Obstructive Sleep Apnea Syndrome (OSAS).

Universidade Federal do Rio de Janeiro·interventional·Posted Jan 12, 2012·Updated Sep 15, 2014

In Brief

A Phase 4 clinical trial evaluating Continuous positive airway pressure treatment for Obstructive Sleep Apnea Syndrome and Resistant Hypertension. Completed, enrolled 125 participants across 1 site.

Detailed Summary

The aim is to evaluate the effect of treatment with Continuous Positive Airway Pressure (CPAP) device on clinic and ambulatory blood pressures (BP) of 200 resistant hypertensive patients with moderate-severe obstructive sleep apnea syndrome (OSAS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea Syndrome, Resistant Hypertension
CountriesBrazil
CollaboratorsFinanciadora de Estudos e Projetos, Conselho Nacional de Desenvolvimento Científico e Tecnológico

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 12, 2012
Enrollment StartJan 1, 2012
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 14.5 years ago

Interventions

Continuous positive airway pressure treatmentprocedure

Treatment with CPAP for 6 months, pressure will be titrated during a second polysomnography.